Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2087 of 6351
-
Can a Child's molecular signature predict growth and development?
Knowledge-focused CompletedPreterm birth (PTB) occurs before 37 weeks of gestation and is a major cause of neonatal mortality and morbidity. PTB results from heterogeneous influences. One of them is the inherited predisposition of spontaneous PTB, and another is the change in the placental microbial compos…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Potato starch may protect stem cell transplant patients from deadly immune attack
Disease control CompletedInvestigators are evaluating the feasibility, safety and early efficacy of administering a commercially available dietary supplement containing potato-based resistant starch to subjects undergoing allogeneic SCT (stem cell transplant). The intervention will begin immediately prio…
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Two-Drug immunotherapy combo shows promise for advanced kidney cancer
Disease control CompletedThe main purpose of this study is to evaluate the effects of the interleukin-2 given in combination with pembrolizumab. Interleukin-2 (IL-2) is also called aldesleukin, or Proleukin™. Pembrolizumab is also called Keytruda™, or anti-PD-1 antibody.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New ultrasound tech aims to sharpen breast cancer detection
Diagnosis By invitation onlyThis study aims to investigate recent developments in ultrasound signal processing to determine if these new techniques can enhance the visibility of important features of interest in breast ultrasound images. Ultrasound signals obtained from both standard ultrasound imaging and …
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Can hormones during pregnancy reshape the Heart's electrical beat?
Knowledge-focused CompletedPregnancy and the postpartum period are accompanied by marked changes in heart rate, circulating hormones, and electrolyte balance that may influence ventricular repolarization. This prospective longitudinal study evaluated adult women during the third trimester of pregnancy and …
Sponsor: French Cardiology Society • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can the HPV vaccine protect stem cell transplant patients?
Vaccine OngoingThis phase IV trial studies how well Gardasil 9 vaccine works in preventing human papillomavirus (HPV) infection in patients with hematologic malignancies who are undergoing donor stem cell transplant. Vaccines, such as Gardasil 9, may help the body build an effective immune resp…
Phase 4 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Jul 18, 2026 00:00 UTC
-
Could a common blood pressure pill stop PTSD before it starts?
Prevention CompletedAfter a traumatic event such as an accident or an assault, victims may experience intense stress symptoms that may evolve into "post-traumatic stress disorder" (PTSD). It is a frequent and serious pathology, which can be complicated by depression, addiction or suicide. Few means …
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy drug avelumab takes on rare thymus cancers
Disease control OngoingBackground: Thymoma and thymic carcinoma are cancers originating in the thymus gland. Platinum-based chemotherapy is standard treatment for them. But not uncommonly, the disease returns and people need more treatment to keep the cancer from growing. The drug Avelumab could help …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New vaccine aims to train immune system against myeloma
Vaccine OngoingThis phase I trial studies the safety of SVN53-67/M57-KLH peptide vaccine in incomplete Freund's adjuvant together with sargramostim in treating patients with newly diagnosed multiple myeloma who are receiving lenalidomide maintenance therapy. Vaccines made from survivin peptide …
Phase 1 • Sponsor: Roswell Park Cancer Institute • Aim: Vaccine
Last updated Jun 27, 2026 12:32 UTC
-
Promising preeclampsia drug trial halted early – what happened?
Disease control Stopped earlyThis study evaluates the use of AMAG-423 (Digoxin Immune Fab) in addition to expectant management in the treatment of severe preeclampsia as compared to placebo.
Phase 2/3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Hope for Hard-to-Treat lung infection: old drug shows promise
Disease control OngoingThe purpose of this study is to evaluate the clinical effectiveness and safety of clofazimine when used to treat Mycobacteria avium complex (MAC) lung disease. Funding Source - FDA OOPD
Phase 2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
HIV study tests which pill combo best shrinks the Virus's hideout
Disease control CompletedThe purpose of this study is to compare the impact of two combination of two tablets once daily: dolutegravir associated with emtricitabine / tenofovir versus darunavir / cobicistat associated with emtricitabine / tenofovir on DNA HIV measured in PBMC at 48 weeks in patients with…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Weekly vs. Every-3-Week cisplatin: which is safer for head and neck cancer?
Disease control OngoingPatients will receive standard of care radiation therapy to the primary tumor of the head and neck and involved nodal metastasis and draining nodal basin and either weekly cisplatin or every 3-week cisplatin in locally advanced SCCHN. The relationship between cisplatin toxicity a…
Phase 2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for mesothelioma? drug targets CD30-Positive tumors
Disease control OngoingThis phase II trial studies how well brentuximab vedotin works in treating patients with CD30 positive (+) malignant mesothelioma that cannot be removed by surgery. Monoclonal antibodies, such as brentuximab vedotin, may interfere with the ability of tumor cells to grow and sprea…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Electric field helmet shows promise for kids with deadly brain cancer
Disease control OngoingThis is a multicenter trial of the Optune device to examine the feasibility and to describe the device-related toxicity in children with supratentorial high grade glioma (HGG) or ependymoma (Stratum 1) and to examine the feasibility and efficacy of concurrent Optune and standard …
Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Vitamin d trial aims to shield kidneys in critical illness
Prevention CompletedThe purpose of this study is to assess the efficacy of calcifediol (25-hydroxyvitamin D) and calcitriol (1,25-dihydroxyvitamin D) in preventing and reducing the severity of acute kidney injury (AKI) in critically ill patients.
Phase 2 • Sponsor: David Leaf • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Gluten: friend or foe for elite athletes?
Knowledge-focused CompletedThis clinical project aims to study the relationship between gluten consumption and its impact on digestive comfort, quality of life and performance of non-celiac athletes practicing an intensive physical activity..
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a common blood thinner shield your brain from dementia?
Disease control CompletedPatients will be screened at Intermountain Medical Center and at Intermountain-affiliated anticoagulation clinics in the Salt Lake City region. Patients with non-valvular atrial fibrillation will be considered for study. After written informed consent is obtained, subjects who me…
Phase 4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Exoskeleton and spinal zaps help paralyzed patients walk again?
Symptom relief Recruiting nowThe overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New emotion training cuts suicide risk in older adults
Symptom relief CompletedThe goal of this trial is to refine and test a novel emotion-regulation based psychosocial intervention designed to reduce suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation o…
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC